Endologix Inc. Reports 28% Fourth Quarter 2009 Revenue Growth and Continued Positive Cash Flow from Operations

IRVINE, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and twelve months ended December 31, 2009.